Abstract
Cyanovirin-N (CV-N) is a 101 amino acid cyanobacterial lectin with potent antiviral activity against HIV, mediated by high-affinity binding to branched N-linked oligomannosides on the viral surface envelope protein gp120. The protein contains two carbohydrate-binding domains, A and B, each of which binds short oligomannosides independently in vitro. The interaction to gp120 could involve either a single domain or both domains simultaneously; it is not clear which mode would elicit the antiviral activity. The model is complicated by the formation of a domain-swapped dimer form, in which part of each domain is exchanged between two monomers, which contains four functional carbohydrate-binding domains. To clarify whether multivalent interactions with gp120 are necessary for the antiviral activity, we engineered a novel mutant, P51G-m4-CVN, in which the binding site on domain A has been knocked out; in addition, a [P51G] mutation prevents the formation of domain-swapped dimers under physiological conditions. Here, we present the crystal structures at 1.8 Å of the free and of the dimannose-bound forms of P51G-m4-CVN, revealing a monomeric structure in which only domain B is bound to dimannose. P51G-m4-CVN binds gp120 with an affinity almost 2 orders of magnitude lower than wt CV-N and is completely inactive against HIV. The tight binding to gp120 is recovered in the domain-swapped version of P51G-m4-CVN, prepared under extreme conditions. Our findings show that the presence of at least two oligomannoside-binding sites, either by the presence of intact domains A and B or by formation of domain-swapped dimers, is essential for activity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 9199-9207 |
| Number of pages | 9 |
| Journal | Biochemistry |
| Volume | 46 |
| Issue number | 32 |
| DOIs | |
| State | Published - Aug 14 2007 |
Fingerprint
ASJC Scopus subject areas
- Biochemistry
Cite this
A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity. / Fromme, Raimund; Katiliene, Zivile; Giomarelli, Barbara; Bogani, Federica; Mc Mahon, James; Mori, Toshiyuki; Fromme, Petra; Ghirlanda, Giovanna.
In: Biochemistry, Vol. 46, No. 32, 14.08.2007, p. 9199-9207.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A monovalent mutant of cyanovirin-N provides insight into the role of multiple interactions with gp120 for antiviral activity
AU - Fromme, Raimund
AU - Katiliene, Zivile
AU - Giomarelli, Barbara
AU - Bogani, Federica
AU - Mc Mahon, James
AU - Mori, Toshiyuki
AU - Fromme, Petra
AU - Ghirlanda, Giovanna
PY - 2007/8/14
Y1 - 2007/8/14
N2 - Cyanovirin-N (CV-N) is a 101 amino acid cyanobacterial lectin with potent antiviral activity against HIV, mediated by high-affinity binding to branched N-linked oligomannosides on the viral surface envelope protein gp120. The protein contains two carbohydrate-binding domains, A and B, each of which binds short oligomannosides independently in vitro. The interaction to gp120 could involve either a single domain or both domains simultaneously; it is not clear which mode would elicit the antiviral activity. The model is complicated by the formation of a domain-swapped dimer form, in which part of each domain is exchanged between two monomers, which contains four functional carbohydrate-binding domains. To clarify whether multivalent interactions with gp120 are necessary for the antiviral activity, we engineered a novel mutant, P51G-m4-CVN, in which the binding site on domain A has been knocked out; in addition, a [P51G] mutation prevents the formation of domain-swapped dimers under physiological conditions. Here, we present the crystal structures at 1.8 Å of the free and of the dimannose-bound forms of P51G-m4-CVN, revealing a monomeric structure in which only domain B is bound to dimannose. P51G-m4-CVN binds gp120 with an affinity almost 2 orders of magnitude lower than wt CV-N and is completely inactive against HIV. The tight binding to gp120 is recovered in the domain-swapped version of P51G-m4-CVN, prepared under extreme conditions. Our findings show that the presence of at least two oligomannoside-binding sites, either by the presence of intact domains A and B or by formation of domain-swapped dimers, is essential for activity.
AB - Cyanovirin-N (CV-N) is a 101 amino acid cyanobacterial lectin with potent antiviral activity against HIV, mediated by high-affinity binding to branched N-linked oligomannosides on the viral surface envelope protein gp120. The protein contains two carbohydrate-binding domains, A and B, each of which binds short oligomannosides independently in vitro. The interaction to gp120 could involve either a single domain or both domains simultaneously; it is not clear which mode would elicit the antiviral activity. The model is complicated by the formation of a domain-swapped dimer form, in which part of each domain is exchanged between two monomers, which contains four functional carbohydrate-binding domains. To clarify whether multivalent interactions with gp120 are necessary for the antiviral activity, we engineered a novel mutant, P51G-m4-CVN, in which the binding site on domain A has been knocked out; in addition, a [P51G] mutation prevents the formation of domain-swapped dimers under physiological conditions. Here, we present the crystal structures at 1.8 Å of the free and of the dimannose-bound forms of P51G-m4-CVN, revealing a monomeric structure in which only domain B is bound to dimannose. P51G-m4-CVN binds gp120 with an affinity almost 2 orders of magnitude lower than wt CV-N and is completely inactive against HIV. The tight binding to gp120 is recovered in the domain-swapped version of P51G-m4-CVN, prepared under extreme conditions. Our findings show that the presence of at least two oligomannoside-binding sites, either by the presence of intact domains A and B or by formation of domain-swapped dimers, is essential for activity.
UR - http://www.scopus.com/inward/record.url?scp=34547916495&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547916495&partnerID=8YFLogxK
U2 - 10.1021/bi700666m
DO - 10.1021/bi700666m
M3 - Article
C2 - 17636873
AN - SCOPUS:34547916495
VL - 46
SP - 9199
EP - 9207
JO - Biochemistry
JF - Biochemistry
SN - 0006-2960
IS - 32
ER -